[HTML] springer.comFull View

[HTML][HTML] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - BMC cancer, 2020 - Springer
Background The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is
very poor. Currently, therapeutic methods for this patient population include whole-brain …
被引用次数：17 相关文章
[PDF] archive.org

[PDF][PDF] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - 2020 - scholar.archive.org
Background: The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is
very poor. Currently, therapeutic methods for this patient population include whole-brain …

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - BMC Cancer, 2020 - go.gale.com
Background The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is
very poor. Currently, therapeutic methods for this patient population include whole-brain …
[HTML] nih.gov

[HTML][HTML] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - BMC Cancer, 2020 - ncbi.nlm.nih.gov
Background The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is
very poor. Currently, therapeutic methods for this patient population include whole-brain …
[HTML] biomedcentral.com

[HTML][HTML] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - BMC Cancer, 2020 - bmccancer.biomedcentral.com
The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is very poor.
Currently, therapeutic methods for this patient population include whole-brain radiation …

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - BMC Cancer, 2020 - hero.epa.gov
The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is very poor.
Currently, therapeutic methods for this patient population include whole-brain radiation …

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - 2020 - search.proquest.com
Background The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is
very poor. Currently, therapeutic methods for this patient population include whole-brain …

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer.

K Liu, G Jiang, A Zhang, Z Li, J Jia - BMC Cancer, 2020 - europepmc.org
BACKGROUND: The prognosis of non-small-cell lung cancer (NSCLC) with brain
metastases is very poor. Currently, therapeutic methods for this patient population include …

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - 2020 - researchsquare.com
Background: The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is
very poor. Currently, therapeutic methods for this patient population include whole-brain …

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

K Liu, G Jiang, A Zhang, Z Li, J Jia - BMC cancer, 2020 - pubmed.ncbi.nlm.nih.gov
Background The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is
very poor. Currently, therapeutic methods for this patient population include whole-brain …